University of California, Irvine
Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.
Profiles
Home
About
Help/FAQs
Search Options
UC Davis
UCI
UCLA
UCSD
UCSF
All UC Health
USC
All
Everything
Research
Concepts
Awards
People
UC Health People
UC Davis People
UCI People
UCLA People
UCSD People
UCSF People
USC People
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Kiran Naqvi
Concepts (182)
Back to Profile
Concepts are derived automatically from a person's publications.
Cloud
Categories
Timeline
Details
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
Academic Medical Centers
Acute Disease
Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Alleles
Anemia, Sideroblastic
Angiogenesis Inhibitors
Animals
Anthracyclines
Antibodies, Monoclonal, Humanized
Antifungal Agents
Antimetabolites
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Arthralgia
Artificial Intelligence
Asparaginase
Azacitidine
Benzeneacetamides
Benzoates
Benzothiazoles
Biomarkers
Biomarkers, Tumor
Biomimetics
Biopsy
Blast Crisis
Blood Component Transfusion
Bone Marrow
Bridged Bicyclo Compounds, Heterocyclic
Cladribine
Clinical Studies as Topic
Clinical Trials as Topic
Clinical Trials, Phase II as Topic
Clonal Evolution
Cohort Studies
Combined Modality Therapy
Comorbidity
Consolidation Chemotherapy
Constipation
Core Binding Factor Alpha 2 Subunit
Cytarabine
Dasatinib
Daunorubicin
Disease-Free Survival
DNA Methylation
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Discovery
Drug Evaluation
Drug Evaluation, Preclinical
Drug Resistance, Neoplasm
Enzyme Inhibitors
Europe
Evidence-Based Medicine
Fatal Outcome
Female
fms-Like Tyrosine Kinase 3
Follow-Up Studies
Fusion Proteins, bcr-abl
Gene Rearrangement
Genetic Predisposition to Disease
Germ-Line Mutation
Glutaminase
Hematologic Neoplasms
Hematopoiesis
Hematopoietic Stem Cell Transplantation
High-Throughput Nucleotide Sequencing
Humans
Hydrazines
Idarubicin
Imatinib Mesylate
Imidazoles
IMP Dehydrogenase
Incidence
Indoles
Induction Chemotherapy
Intensive Care Units
Intervertebral Disc Degeneration
Intracranial Hemorrhages
Intubation, Intratracheal
Janus Kinase 2
Kaplan-Meier Estimate
Leukemia
Leukemia, Biphenotypic, Acute
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Leukemia, Myeloid
Leukemia, Myeloid, Acute
Leukemia, Myeloid, Chronic-Phase
Leukemia, Myelomonocytic, Chronic
Leukemia, Promyelocytic, Acute
Leukocyte Count
Li-Fraumeni Syndrome
L-Lactate Dehydrogenase
Lymphocyte Activation
Maintenance Chemotherapy
Male
Medical Oncology
Middle Aged
Models, Biological
Molecular Targeted Therapy
Mutation
Mycoses
Myelitis, Transverse
Myelodysplastic Syndromes
Myelodysplastic-Myeloproliferative Diseases
Myeloid Cell Leukemia Sequence 1 Protein
Myeloproliferative Disorders
Neoplasm Proteins
Neoplasm Recurrence, Local
Neoplasms
Neoplasms, Second Primary
Neutropenia
Nitriles
Nuclear Proteins
Optic Neuritis
Patient Transfer
Pedigree
Peptide Fragments
Phenylurea Compounds
Philadelphia Chromosome
Pilot Projects
Platelet Count
Pneumonia
Polyethylene Glycols
Positron Emission Tomography Computed Tomography
Practice Guidelines as Topic
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Primary Myelofibrosis
Prognosis
Programmed Cell Death 1 Receptor
Propensity Score
Prospective Studies
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Proteomics
Proto-Oncogene Proteins
Pyrazoles
Pyridazines
Pyridines
Pyrimidines
Pyrrolidines
Quality of Life
Recurrence
Remission Induction
Repressor Proteins
Reproducibility of Results
Retrospective Studies
Risk
Risk Assessment
Risk Factors
Sarcoma, Myeloid
Serum Albumin
Signal Transduction
Skin Neoplasms
Skin Ulcer
Staurosporine
Sulfonamides
Survival
Survival Analysis
Survival Rate
Tandem Repeat Sequences
Thiadiazoles
Thrombocytopenia
Thrombocytosis
Time Factors
Translocation, Genetic
Transplantation, Homologous
Treatment Outcome
Tretinoin
Triazoles
Tumor Suppressor Protein p53
United States
Vidarabine
Water-Electrolyte Imbalance
Withholding Treatment
World Health Organization
Young Adult
Kiran's Networks
Concepts (182)
Derived automatically from this person's publications.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Leukemia, Myeloid, Acute
Cytarabine
Fusion Proteins, bcr-abl
Myelodysplastic Syndromes
Explore
_
Co-Authors (19)
People in Profiles who have published with this person.
Cortes, Jorge
UCSD
Jeyakumar, Deepa
UCI
Griffin, Shawn
UCI
Kongtim, Piyanuch
UCI
Ciurea, Stefan
UCI
Explore
_
Similar People (60)
People who share similar concepts with this person.
Cortes, Jorge
UCSD
Shah, Neil Pravin
UCSF
Jonas, Brian
UC Davis
Smith, Catherine
UCSF
Schiller, Gary
UCLA
Explore
_
Same Department
Munley, Daniel
Sasson, Bobby
Sassoon, Catherine
Yazdanpanah, Omid
Yu, Katherine
Search Department
_